SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?


To: EightyEight who wrote (976)7/7/2000 4:16:55 PM
From: Susan G  Read Replies (1) | Respond to of 1298
 
Audio: ON24/Briefing.com: Spotlight: Cell Genesys

================================================================
Cell Genesys' great cash position is even more impressive than its patent portfolio.
<A HREF="http://www.on24.com/vuwindow/scripts/vuwin.asp?ref=quot&cb=quot&id=29562&type=av">http://www.on24.com/vuwindow/scripts/vuwin.asp?ref=quot&cb=quot&id=29562&type=av</A>
<SCRIPT>window.open('http://www.on24.com/vuwindow/scripts/vuwin.asp?ref=quot&cb=quot&id=29562&type=av')</SCRIPT>



To: EightyEight who wrote (976)7/10/2000 9:40:12 PM
From: Gemini  Read Replies (3) | Respond to of 1298
 
According to my calculations, CEGE has in excess of ONE
BILLION DOLLARS in cash based upon today's market close.

In-house, it has 585.5 million. In addition, its 12%
position in ABGX equates to approximately 675 million for
a grand total of approximately 1.260 billion in cash and
cash equivalents.

biz.yahoo.com

What's also absolutely amazing is the fact that CEGE has
a market cap of only 1.132 billion as of the close today.

When was the last time anyone has ever heard of an established public company having a higher cash position than its total market capitalization?

I do not believe I ever have.

Cash truly is KING and Wall Street is finally recognizing management's accomplishments.

All the best, Allan